Who has invested in NLS Pharma?

Kadimastem are named among the investors backing NLS Pharma.

NLS Pharma Funding: $3M Raised, Series B (2025)

NLS Pharma funding overview

NLS Pharma is based in Zurich, Switzerland. NLS Pharma has raised $3M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series B announced in June 2025. The round record for NLS Pharma runs through 2025; nothing later has been disclosed. Investors on record include Kadimastem.

NLS Pharma at a glance

Total raised: $3M
Latest round: Series B
Latest round date: June 2025
Headquarters: Zurich, Switzerland
Notable investors: Kadimastem

Frequently asked about NLS Pharma funding

How much has NLS Pharma raised?: NLS Pharma has raised $3M in total disclosed funding across the rounds on record.
Who has invested in NLS Pharma?: Kadimastem are named among the investors backing NLS Pharma.
What was the latest NLS Pharma funding round?: The most recent disclosed round is a Series B, announced in June 2025.
Where is NLS Pharma based?: NLS Pharma is based in Zurich, Switzerland.
When did NLS Pharma last raise?: The last disclosed NLS Pharma round closed in June 2025 at Series B.

We update the NLS Pharma record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Zurich and their backers are listed below.

NLS Pharma Funding: $3M Raised, Series B (2025)

NLS Pharma funding overview

NLS Pharma at a glance

Frequently asked about NLS Pharma funding

Companies related to NLS Pharma (18)

Browse related funding lists (3)